⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2625692 | 0.74 | — | — | |
| SCHEMBL6283784 | 0.74 | TSHR (0.41) | — | |
| SCHEMBL153002 | 0.72 | — | — | |
| SCHEMBL16405076 | 0.71 | TSHR (0.35) | — | |
| SCHEMBL13568625 | 0.71 | TSHR (0.42) | — | |
| SCHEMBL8027721 | 0.70 | — | — | |
| SCHEMBL31674415 | 0.69 | — | — | |
| SCHEMBL5846168 | 0.69 | TSHR (0.40) | — | |
| SCHEMBL4271924 | 0.69 | TSHR (0.33) | — | |
| SCHEMBL237697 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 193 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12531269-B2 | Silicon-based energy storage devices with fluorinated electrolyte formulations | ENEVATE CORPORATION (US) | 2026-01-20 | — | — | US | claimed |
| CN-111808531-B | Decorative coating capable of decomposing formaldehyde and releasing high-concentration negative oxygen ions | 佛山市邦韵建材有限公司 | 2021-07-30 | — | — | CN | claimed |
| US-20200388882-A1 | SILICON-BASED ENERGY STORAGE DEVICES WITH FLUORINATED ELECTROLYTE FORMULATIONS | ENEVATE CORPORATION | 2020-12-10 | — | — | US | claimed |
| CN-111808531-A | Decorative coating capable of decomposing formaldehyde and releasing high-concentration negative oxygen ions | 吴晨伟 | 2020-10-23 | — | — | CN | claimed |
| US-12531269-B2 | Silicon-based energy storage devices with fluorinated electrolyte formulations | ENEVATE CORPORATION (US) | 2026-01-20 | — | — | US | disclosed |
| US-12391664-B2 | GluN2C/D subunit selective antagonists of the N-methyl-D-aspartate receptor | EMORY UNIVERSITY (US) | 2025-08-19 | — | — | US | disclosed |
| US-12344597-B2 | Alkoxy-substituted pyridinyl derivatives as LPA1 receptor antagonists and their use in the treatment of fibrosis | IDORSIA PHARMACEUTICALS LTD (CH) | 2025-07-01 | — | — | US | disclosed |
| US-20240294493-A1 | GluN2C/D Subunit Selective Antagonists of the N-Methyl-D-Aspartate Receptor | UNIV EMORY (US) | 2024-09-05 | — | — | US | disclosed |
| EP-4391139-A1 | ELECTROLYTE SOLUTION, ELECTROCHEMICAL DEVICE, SECONDARY BATTERY, AND LITHIUM ION SECONDARY BATTERY | DAIKIN INDUSTRIES, LTD. (JP) | 2024-06-26 | — | — | EP | disclosed |
| US-12015121-B2 | Electrolyte, electrochemical device, lithium ion secondary battery, and module | DAIKIN INDUSTRIES, LTD. (JP) | 2024-06-18 | — | — | US | disclosed |
| CN-111919326-B | Electrolyte, electrochemical device, lithium ion secondary battery, assembly, and compound | 大金工业株式会社 | 2024-06-11 | — | — | CN | disclosed |
| CN-113490674-B | Compound, additive for electrolyte, electrochemical device, lithium ion secondary battery, and module | 大金工业株式会社 | 2024-06-07 | — | — | CN | disclosed |
| US-4778926-A | ANTITUMOR AND ANTIGROWTH AGENTS; CHEMICAL INTERMEDIATES | MERRELL DOW PHARMACEUTICALS INC. (US) | 1988-10-18 | — | — | US | disclosed |
| US-4719313-A | ANTITUMOR | MERRELL DOW PHARMACEUTICALS INC. (US) | 1988-01-12 | — | — | US | disclosed |
| US-4695654-A | ANTITUMOR AGENTS | MERRELL DOW PHARMACEUTICALS INC. (US) | 1987-09-22 | — | — | US | disclosed |
| EP-0220409-A2 | Gem-dihalo and tetrahalo-1,12-diamino-4,9-diaza-dodecanes | MERRELL DOW PHARMACEUTICALS INC. (US) | 1987-05-06 | — | — | EP | disclosed |
| EP-0215319-A2 | Gem-dihalo-1,8-diamino-4-aza-octanes | MERRELL DOW PHARMACEUTICALS INC. (US) | 1987-03-25 | — | — | EP | disclosed |
| US-4599330-A | 24,24-DIFLUORO-1,25-DIHYDROXYCHOLECALCIFEROL | HOFFMANN-LA ROCHE INC. (US) | 1986-07-08 | — | — | US | disclosed |
| US-4421690-A | ANTI-RACHITOGENIC | HOFFMANN-LA ROCHE INC. (US) | 1983-12-20 | — | — | US | disclosed |
| US-4397847-A | OF OSTEOPOROSIS WITH 24,24-DIFLUORO-1,25-DIHYDROXYCHOLECALCIFEROL | HOFFMANN-LA ROCHE INC. (US) | 1983-08-09 | — | — | US | disclosed |